References

References

Screening References

1. Yau, J.W., et al., Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care, 2012. 35(3): p. 556-64.

2. Lee, R., T.Y. Wong, and C. Sabanayagam, Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye Vis (Lond), 2015. 2: p. 17.

3. Leasher, J.L., et al., Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010. Diabetes Care, 2016. 39(9): p. 1643-9.

4. Fong, D.S., et al., Diabetic retinopathy. Diabetes Care, 2003. 26 Suppl 1: p. S99-S102.

5. Thomas, R.L., et al., Retrospective analysis of newly recorded certifications of visual impairment due to diabetic retinopathy in Wales during 2007-2015. BMJ Open, 2017. 7(7): p. e015024.

6. Grauslund, J., et al., Evidence-based Danish guidelines for screening of diabetic retinopathy. Acta Ophthalmol, 2018. 96(8): p. 763-769.

7. Wang, L.Z., et al., Availability and variability in guidelines on diabetic retinopathy screening in Asian countries. Br J Ophthalmol, 2017. 101(10): p. 1352-1360.

8. Foundation., I.D.F.a.T.F.H., Diabetes eye health: A guide for health care professionals. Brussels, Belgium: International Diabetes Federation, 2015. www.idf.org/eyecare.

9. Fathy, C., et al., Disparities in Adherence to Screening Guidelines for Diabetic Retinopathy in the United States: A Comprehensive Review and Guide for Future Directions. Semin Ophthalmol, 2016. 31(4): p. 364-77.

10. Salamanca, O., et al., Implementation of a diabetic retinopathy referral network, Peru. Bull World Health Organ, 2018. 96(10): p. 674-681.

11. Wong, I.Y.H., et al., Saving sight in China and beyond: the Lifeline Express model. BMJ Glob Health, 2018. 3(4): p. e000766.

12. Tanaka, H., et al., Process quality of diabetes care under favorable access to healthcare: a 2-year longitudinal study using claims data in Japan. BMJ Open Diabetes Res Care, 2016. 4(1): p. e000291.

13. Mash, B., et al., Screening for diabetic retinopathy in primary care with a mobile fundal camera–evaluation of a South African pilot project. S Afr Med J, 2007. 97(12): p. 1284-8.

14. Cleland, C.R., et al., Diabetic retinopathy screening: experiences from northern Tanzania. Lancet Diabetes Endocrinol, 2016. 4(1): p. 10-2.

15. Malerbi, F.K., et al., Comparison between binocular indirect ophthalmoscopy and digital retinography for diabetic retinopathy screening: the multicenter Brazilian Type 1 Diabetes Study. Diabetol Metab Syndr, 2015. 7: p. 116.

16. Javitt, J.C. and L.P. Aiello, Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med, 1996. 124(1 Pt 2): p. 164-9.

17. Sculpher, M.J., et al., Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies. Health Econ, 1992. 1(1): p. 39-51.

18. Jones, S. and R.T. Edwards, Diabetic retinopathy screening: a systematic review of the economic evidence. Diabet Med, 2010. 27(3): p. 249-56.

19. Ting, D.S., G.C. Cheung, and T.Y. Wong, Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol, 2016. 44(4): p. 260-77.

20. Wong, T.Y., et al., Guidelines on Diabetic Eye Care: The International Council of Ophthalmology Recommendations for Screening, Follow-up, Referral, and Treatment Based on Resource Settings. Ophthalmology, 2018. 125(10): p. 1608-1622.

21. Burgess, P.I., G. Msukwa, and N.A. Beare, Diabetic retinopathy in sub-Saharan Africa: meeting the challenges of an emerging epidemic. BMC Med, 2013. 11: p. 157.

22. Zimmer-Galler, I.E. and R. Zeimer, Telemedicine in diabetic retinopathy screening. Int Ophthalmol Clin, 2009. 49(2): p. 75-86.

23. Tozer, K., M.A. Woodward, and P.A. Newman-Casey, Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs. J Endocrinol Diabetes, 2015. 2(4).

24. Jani, P.D., et al., Evaluation of Diabetic Retinal Screening and Factors for Ophthalmology Referral in a Telemedicine Network. JAMA Ophthalmol, 2017. 135(7): p. 706-714.

25. Pasquel, F.J., et al., Cost-effectiveness of Different Diabetic Retinopathy Screening Modalities. J Diabetes Sci Technol, 2015. 10(2): p. 301-7.

26. Li, Z., et al., Telemedicine-based digital retinal imaging vs standard ophthalmologic evaluation for the assessment of diabetic retinopathy. Conn Med, 2012. 76(2): p. 85-90.

27. Khan, T., et al., Preventing diabetes blindness: cost effectiveness of a screening programme using digital non-mydriatic fundus photography for diabetic retinopathy in a primary health care setting in South Africa. Diabetes Res Clin Pract, 2013. 101(2): p. 170-6.

28. Micheletti, J.M., et al., Current and Next Generation Portable Screening Devices for Diabetic Retinopathy. J Diabetes Sci Technol, 2016. 10(2): p. 295-300.

29. Ryan, M.E., et al., Comparison Among Methods of Retinopathy Assessment (CAMRA) Study: Smartphone, Nonmydriatic, and Mydriatic Photography. Ophthalmology, 2015. 122(10): p. 2038-43.

30. Scotland, G.S., et al., Cost-effectiveness of implementing automated grading within the national screening programme for diabetic retinopathy in Scotland. Br J Ophthalmol, 2007. 91(11): p. 1518-23.

31. Keel, S., et al., Feasibility and patient acceptability of a novel artificial intelligence-based screening model for diabetic retinopathy at endocrinology outpatient services: a pilot study. Sci Rep, 2018. 8(1): p. 4330.

32. van der Heijden, A.A., et al., Validation of automated screening for referable diabetic retinopathy with the IDx-DR device in the Hoorn Diabetes Care System. Acta Ophthalmol, 2018. 96(1): p. 63-68.

33. Strutton, R., et al., System-level and patient-level explanations for non-attendance at diabetic retinopathy screening in Sutton and Merton (London, UK): a qualitative analysis of a service evaluation. BMJ Open, 2016. 6(5): p. e010952.

34. Kashim, R.M., P. Newton, and O. Ojo, Diabetic Retinopathy Screening: A Systematic Review on Patients’ Non-Attendance. Int J Environ Res Public Health, 2018. 15(1).

Innovation References

1. Goh, J.K., et al., Retinal Imaging Techniques for Diabetic Retinopathy Screening. J Diabetes Sci Technol, 2016. 10(2): p. 282-94.

2. Ishibazawa, A., et al., Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study. Am J Ophthalmol, 2015. 160(1): p. 35-44 e1.

3. Ghasemi Falavarjani, K., et al., Ultra-wide-field imaging in diabetic retinopathy; an overview. J Curr Ophthalmol, 2016. 28(2): p. 57-60.

4. Wessel, M.M., et al., Ultra-wide-field angiography improves the detection and classification of diabetic retinopathy. Retina, 2012. 32(4): p. 785-91.

5. Blair, N.P., et al., Retinal Oximetry and Vessel Diameter Measurements With a Commercially Available Scanning Laser Ophthalmoscope in Diabetic Retinopathy. Invest Ophthalmol Vis Sci, 2017. 58(12): p. 5556-5563.

6. Fenner, B.J., et al., Advances in Retinal Imaging and Applications in Diabetic Retinopathy Screening: A Review. Ophthalmol Ther, 2018. 7(2): p. 333-346.

7. Simo, R., et al., Effects of Topically Administered Neuroprotective Drugs in Early Stages of Diabetic Retinopathy. Results of the EUROCONDOR Clinical Trial. Diabetes, 2018.

8. Final Report Summary – EUROCONDOR (European Consortium for the Early Treatment of Diabetic Retinopathy). https://cordis.europa.eu/result/rcn/189871_en.html.

9. Patel, J.I., et al., Angiopoietin concentrations in diabetic retinopathy. Br J Ophthalmol, 2005. 89(4): p. 480-3.

10. Campochiaro, P.A., et al., Enhanced Benefit in Diabetic Macular Edema from AKB-9778 Tie2 Activation Combined with Vascular Endothelial Growth Factor Suppression. Ophthalmology, 2016. 123(8): p. 1722-1730.

11. Bhat, M., et al., The kallikrein-kinin system in diabetic retinopathy. Prog Drug Res, 2014. 69: p. 111-43.

12. http://www.modernretina.com/modern-retina/news/alg-1001-turning-machinery-angiogenesis.

13. Kusuhara, S., et al., Pathophysiology of Diabetic Retinopathy: The Old and the New. Diabetes Metab J, 2018. 42(5): p. 364-376.